To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
Clinical trial NCT02321397 · COMPLETED
Trial details
- NCT number
- NCT02321397
- Sponsor
- Mundipharma Research GmbH & Co KG
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-03-01
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.